* Corresponding Author
Synthesis, Multi-Identifications of Some Complexes with a Newly Ligand (4-FADPD) Derived from Caffeine and Evaluation of the Anticancer Activity of Au(III) Nano-Complex
https://doi.org/10.22146/ijc.110949 Majida Ibrahim Obaid(1), Ibtihal Kadhim Kareem(2*), Wurood Ali Jaafar(3)
(1) Department of Chemistry, Faculty of Education for Women, Kufa University, Najaf 54001, Iraq
(2) Department of Chemistry, Faculty of Education for Women, Kufa University, Najaf 54001, Iraq
(3) Department of Chemistry, College of Education for Pure Science (Ibn Al-Haitham), University of Baghdad, Adamiyah, P.O. Box 4150, Baghdad, Iraq
(*) Corresponding Author
Abstract
A novel ligand ((1E)-(2-(4-fluorobenzylidene)amino)methyl) phenyl)diazenyl)-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione (4-FADPD) was synthesized via the azotization reaction of 2-aminobenzylamine with caffeine, and the resultant compound was condensed with 4-fluorobenzaldehyde to form a newly azo-Schiff base ligand. Its complexes with Cu(II), Ag(I), and Au(III) were synthesized. The results of multi-identifications, including XRD, elemental analysis (C.H.N), UV-vis spectroscopy, FTIR, and 1H-NMR, were used to propose the suggested structures using molar conductivity measurements. These data were utilized to propose appropriate geometric configurations for all complexes. The azo-Schiff base ligand coordinates toward the Cu(II) ion in octahedral geometry and Ag(I) ion in tetrahedral geometry, whereas the Au(III) ion gives it a square planar structure. Nanoparticle size was determined using scanning microscopy (FE-SEM). Significant antiproliferative activity was observed with the Au(III) nanocomplex against human lung cancer (A549) cells, compared with normal cell lines (HDFn), as indicated by the IC50 values. The purpose of our research is to prepare new nanocomplexes derived from caffeine and to demonstrate the effectiveness of an Au(III) nanocomplex against lung cancer as a future treatment that may benefit pharmaceutical preparations.
Keywords
References
[1] Zafar, W., Ashfaq, M., and Sumrra, S.H., 2023, A review on the antimicrobial assessment of triazole-azomethine functionalized frameworks incorporating transition metals, J. Mol. Struct., 1288, 135744.
[2] Mohamed, A.R., 2024, Digging into biochemical and signal transduction of old drugs: Xanthines and their association to cancer, ERU Res. J., 3 (1), 849–870.
[3] Park, S.Y., Kim, S.B., Wan, J., Felice, F., and Yi, K.H., 2024, Lipolytic agents for submental fat reduction: Review, Skin Res. Technol., 30 (2), e13601.
[4] Kapri, A., Pant, S., Gupta, N., and Nain, S., 2022, Recent advances in the biological significance of xanthine and its derivatives: A review, Pharm. Chem. J., 56 (4), 461–474.
[5] Yadav, K., Yadav, D., Bhandari, D.D., and Yadav, R., 2022, Identification of 1,3-(dimethyl/propyl)-8-susbtituted (cinnamic acid/furan) xanthine derivatives with anti-bronchospasmodic activity using in silico and in vivo techniques, ChemistrySelect, 7 (17), e202200377.
[6] Malík, M., and Tlustoš, P., 2022, Nootropics as cognitive enhancers: Types, dosage and side effects of smart drugs, Nutrients, 14 (16), 3367.
[7] Yu, H., Chen, X., Guo, X., Chen, D., Jiang, L., Qi, Y., Shao, J., Tao, L., Hang, J., Lu, G., Chen, Y., and Li, Y., 2023, The clinical value of serum xanthine oxidase levels in patients with acute ischemic stroke, Redox Biol., 60, 102623.
[8] Chang, B., Niu, C., and Jiang, Y., 2024, Xanthine or hypoxanthine or both may play therapeutical effect in Parkinson's disease through the endocannabinoid system, Med. Hypotheses, 182, 111231.
[9] Lee, Y., Hwang, J., Desai, S.H., Li, X., Jenkins, C., Kopp, J.B., Winkler, C.A., and Cho, S.K., 2022, Efficacy of xanthine oxidase inhibitors in lowering serum uric acid in chronic kidney disease: A systematic review and meta-analysis, J. Clin. Med., 11 (9), 2468.
[10] Majhi, S., 2023, Recent developments in the synthesis and anti-cancer activity of acridine and xanthine-based molecules, Phys. Sci. Rev., 8 (9), 2405–2439.
[11] Sherefedin, U., Belay, A., Gudishe, K., Kebede, A., Kumela, A.G., and Asemare, S., 2025, Photophysical properties of sinapic acid and ferulic acid and their binding mechanism with caffeine, J. Fluoresc., 35 (4), 2379–2393.
[12] Khavari, F., Taheri, M., Manoochehri, H., Molaei, P., and Nouri, F., 2024, Evaluation of the combined effect of caffeine and 5-fluorouracil on colorectal cancer cell lines, Asian Pac. J. Cancer Prev., 25 (4), 1419–1424.
[13] Gencoglu, H., Delioglu, S., Nergiz, M.A., Metin, R., Erten, F., Tokmak, M., Orhan, C., and Sahin, K., 2026, Synergistic effects of caffeine and paclitaxel in breast cancer cells: Mechanistic insights into NF-κB and Nrf2 signaling, Cell Biochem. Funct., 44 (2), e70183.
[14] Peasah, E.B., Gyampoh, S., Kumar, S., Tanwieh, E.R., Nji, M.I., Asamoah, S., Neba, M C., Aba, C.M.S., 2024, Investigation of the interaction between xanthines and commercial antimicrobials on selected microbes, ISAR J. Med. Pharm. Sci., 2 (6), 24–33.
[15] Yani, M.A.O., Ali, T.F.S., Beshr, E.A.M., Hayallah, A.M., 2024, Recent innovations in biological activities of xanthine and its derivatives: A review, S. Sphinx J. Pharm. Med. Sci., 8 (1), 19–39.
[16] Ali, S.A., Elzawi, N.R., and Elyassiry, A.M., 2021, Synergistic and antagonistic effects of azo-Schiff base with some antibiotics on Gram-positive bacterial isolates, Res. Rev.: J. Microbiol. Virol., 11 (2), 25–31.
[17] Ashoor, L.S., Majeed, R.A., and Al-Shemary, R.K.R., 2021, Applications of biological of azo-Schiff base ligand and its metal complexes and: A review, Muthanna J. Pure Sci., 8 (1), 74–90.
[18] Mohammed, K.F., and Hasan, H.A., 2022, Synthesis, chemical and biological activity studies of azo-Schiff base ligand and its metal complexes, Chem. Methodol., 6 (12), 905–913.
[19] Mandal, P., 2024, Synthesis, characterization and a few noticeable properties of Ni(II) complexes embedded with azo (-N=N-) and azomethine (-C=N-) ligands: A brief review, Chem. Rev. Lett., 7 (1), 65–122.
[20] Ispir, E., Ikiz, M., Inan, A., Sünbül, A.B., Tayhan, S.E., Bilgin, S., Köse, M., and Elmastaş, M., 2019, Synthesis, structural characterization, electrochemical, photoluminescence, antiproliferative and antioxidant properties of Co(II), Cu(II) and Zn(II) complexes bearing the azo-azomethine ligands, J. Mol. Struct., 1182, 63–71.
[21] Elbadawy, H.A., Eldissouky, A., El-Apasery, M.A., Elsayed, D.S., and Alaswad, E.A., 2025, Synthesis, characterization, computational and dyeing behavior of Cu(II) and Zn(II) metal complexes derived from azo-Schiff bases containing phenol derivatives, BMC Chem., 19 (1), 207.
[22] Obaid, H.T., Kadhum, M.Y., and Abdulnabi, A.S., 2022, Azo Schiff base derived from 2-hydroxy-1-naphthaldehyde as corrosion inhibitors for carbon steel in HCl medium: Experimental and theoretical studies, Mater. Today: Proc., 60 (Pt. 3), 1394–1401.
[23] Mahdi, D.M., and Naser, A.W., 2024, Synthesis, characterizations, biological activity and molecular docking study of new azo Schiff -bases, Adv. J. Chem. A, 7 (6), 842–852.
[24] Menati, S., Azadbakht, R., Rudbari, H.A., and Bruno, G., 2021, Synthesis and characterization of four new azo-Schiff base and their nickel(II) complexes, Polyhedron, 205, 115296.
[25] Adnan, S., Al-Adilee, K.J., and Abedalrazaq, K.A., 2020, Synthesis, spectral characterization and anticancer studies of novel azo Schiff base and its complexes with Ag(I), Au(lll) and Pt(lV) ions, Egypt. J. Chem., 63 (12), 4749–4756.
[26] Slassi, S., El-Ghayoury, A., Aarjane, M., Yamni, K., and Amine, A., 2020, New copper(II) and zinc(II) complexes based on azo Schiff base ligand: Synthesis, crystal structure, photoisomerization study and antibacterial activity, Appl. Organomet. Chem., 34 (3), e5503.
[27] Rafique, S., Idrees, M., Nasim, A., Akbar, H., Athar, A., 2010 Transition metal complexes as potential therapeutic agents, Biotechnol. Mol. Biol. Rev., 5 (2), 38-45.
[28] Shumi, G., Desalegn, T., Demissie, T.B., Ramachandran, V.P., and Eswaramoorthy, R., 2022, Metal complexes in target-specific anticancer therapy: Recent trends and challenges, J. Chem., 2022 (1), 9261683.
[29] Doostmohammadi, A., Jooya, H., Ghorbanian, K., Gohari, S., and Dadashpour, M., 2024, Potentials and future perspectives of multi-target drugs in cancer treatment: The next generation anti-cancer agents, Cell Commun. Signaling, 22 (1), 228.
[30] Puzzo, M., De Santo, M., Morelli, C., Leggio, A., and Pasqua, L., 2024, The advent of molecular targeted therapies against cancer. Toward multi-targeting drugs through materials engineering: A possible future scenario, Small Sci., 4 (8), 2400113.
[31] Kareem, I.K., and Hadi, M.A., 2020, Synthesis and characterization of some transition metal complexes with new azo-Schiff base ligand 3,4-bis(((1E,2E)-2-((2-((4-((Z)-(3-hydroxyphenyl)diazenyl)naphthalen-1-yl)amino)ethyl)imino)-1,2-diphenylethylidene)amino)phenyl)(phenyl)methanone, Egypt. J. Chem., 63 (1), 301–313.
[32] Jawad, S.A.A., and Kareem, I.K., 2022, Synthesis, characterization and biological study of open multi dentate new azo-Schiff ligand and it’s divalent metal ion complexes with copper, zinc and mercury, AIP Conf. Proc., 2386 (1), 030014.
[33] Sherif, S., Aboelnaga, A., Elshemy, N.S., Elabbadya, S., and Ramadan, S.K., 2026, Design and synthesis of novel sulfa-azo dyes: A sustainable approach to textile dyeing combined with microwave energy, RSC Adv., 16 (6), 5374–5400.
[34] Al-adilee, K.J., and Hessoon, H.M., 2019, Synthesis, spectral properties and anticancer studies of novel hetrocyclic azo dye ligand derived from 2-amino-5-methyl thiazole with some transition metal complexes, J. Phys.: Conf. Ser., 1234 (1), 012094.
[35] Noor, S.S., and Kareem, I.K., 2024, Exploring the anticancer activity of gold complex with newly ligand (DDIBM): Synthesis, spectral identification and magnetic susceptibility of its metallic complexes, Indones. J. Chem., 24 (3), 822–834.
[36] Kyhoiesh, H.A.K., and Hassan, H.M., 2024, Synthesis, characterization, in silico DFT, molecular docking, ADMET profiling studies and toxicity predictions of Ag(I) complex derived from 4-aminoacetophenone, ChemistrySelect, 9 (4), e202304429.
[37] Sami, S., and Shaalan, N., 2024, Synthesis, structure, and biological activity studies of new metal ion complexes based on 3-[(3-hydroxynaphthalene-2-yl-ethylidene)-hydrazono]-1,3-dihydro-indol-2-one, Indones. J. Chem., 24 (2), 370–378.
[38] Hussein, N.A., and Abbas, A.K., 2022, Synthesis, spectroscopic characterization and thermal study of some transition metal complexes derived from caffeine azo ligand with some of their applications, J. Med. Pharm. Chem. Res., 4 (1), 67–93.
[39] Obaid, M.I., and Jaafar, W.A, 2022, Formation, characterization and thermal study of novel Schiff base ligand from sulfonic acid and its complexes with Co(II), Ni(II), Cu(II), Zn(II) and Hg(II) type NO, Chem. Methodol., 6 (6) 457–462.
[40] Ali, A.M., and Hassani, Z.R., 2020, Preparation and characterization of new azo ligand and some of its chelate complexes, J. Kufa Chem. Sci., 2 (6), 13–23.
[41] Hilal, T.A.A., and Kareem, I.K., 2025, Synthesis of some metal complexes with new heterocyclic ligand (5-(((2-(3-(1H-indol-3-yl)acryloyl)phenyl)amino)methylene)-2-thiooxodihydropyrimidine-4,6(1H,5H)-dione) and their biological effectiveness as antioxidant and anti-cancer, Indones. J. Chem., 25 (1), 60–75.
[42] Jaafar, W.A, and Saeed, R.S., 2020, Synthesis, characterization and corrosion inhibition study of new heterocyclic compounds and Schiff base with [Co (II), Ni (II), Cu (II) and Hg (II)] complexes, Syst. Rev. Pharm., 11 (10), 134–143.
[43] Al-Hasnawi, F., Abdul Karem, L.K., and Mortatha, D.M., (2023). Synthesis, physicochemical elucidation and biological screening study of new ligand derived from 5,6-O-isopropylidene-L-ascorbic acid and its metal(II) complexes, Malays. J. Sci., 42 (3), 45–55.
[44] Radhi, S.M.J., Kareem, I.K., and Majeed, N.S., 2023, Preparation and characterization of new mixed ligand complexes for some transition metal ions (bivalent) with Schiff-Mannich and Schiff base ligands, J. Kufa Chem. Sci., 3 (1), 1–25.
[45] Yahya, W.I., Mgheed, T.H., and Kadhium, A.J., 2022, Preparation, characterization of some metal complexes of new mixed ligands derived from 5-methyl imidazole and study the biological activity of palladium(II) complex as anticancer, NeuroQuantology, 20 (1), 71–83.
[46] Mohd Makhtar, S.N.N., Abd Hamed, N.K., and bin Hamdan, M.A.H., 2024, “Morphological analysis of photocatalytic membrane (SEM, FESEM, TEM)” in Advanced Ceramics for Photocatalytic Membranes, Elsevier, Amsterdam, Netherlands, 221–238.
[47] Aziz, A., Shaikh, H., Abbas, A., Zehra, K., and Javed, B., 2025, Microscopic techniques for nanomaterials characterization: A concise review, Microsc. Res. Tech., 88 (5), 1599–1614.
[48] Yasir, A.F., and Jamel, H.O., 2023, Synthesis of a new DPTYEAP ligand and its complexes with their assessments on physical properties, antioxidant, and biological potential to treat breast cancer, Indones. J. Chem., 23 (3), 796–808.
[49] Ali, A., Chiang, Y.W., and Santos, R.M., 2022, X-ray diffraction techniques for mineral characterization: A review for engineers of the fundamentals, applications, and research directions, Minerals, 12 (2), 205.
[50] El-Boraey, H.A., and El-Domiaty, A.M., 2021, Influences of γ-ray irradiation on physico-chemical, structural, X-ray diffraction, thermal and antimicrobial activity of some γ-irradiated N′,N′′′-((Z)-ethane-1,2-diylidine)bis(2-aminobenzohydrazide) metal complexes, Appl. Radiat. Isot., 174, 109774.
[51] Nasiri, S., Rabiei, M., Palevicius, A., Janusas, G., Vilkauskas, A., Nutalapati, V., and Monshi, A., 2023, Modified Scherrer equation to calculate crystal size by XRD with high accuracy, examples Fe2O3, TiO2 and V2O5, Nano Trends, 3, 100015.
[52] Fatimah, S., Ragadhita, R., Al Husaeni, D.F., and Nandiyanto, A.B.D., 2021, How to calculate crystallite size from X-ray diffraction (XRD) using Scherrer method, Asean J. Sci. Eng., 2 (1), 65–76.
[53] Kyhoiesh, H.A.K., and Al-Adilee, K.J., 2023, Pt(IV) and Au(III) complexes with tridentate-benzothiazole based ligand: Synthesis, characterization, biological applications (antibacterial, antifungal, antioxidant, anticancer and molecular docking) and DFT calculation, Inorg. Chim. Acta, 555, 121598.
[54] Kyhoiesh, H.K.A., and Al-Adilee, K.J., 2021, Synthesis, spectral characterization, antimicrobial evaluation studies and cytotoxic activity of some transition metal complexes with tridentate (N,N,O) donor azo dye ligand, Results Chem., 3, 100245.
DOI: https://doi.org/10.22146/ijc.110949
Article Metrics
Abstract views : 3
| 
views : 0
| views : 0
Copyright (c) 2026 Indonesian Journal of Chemistry
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Indonesian Journal of Chemistry (ISSN 1411-9420 /e-ISSN 2460-1578) - Chemistry Department, Universitas Gadjah Mada, Indonesia.